What is Livalo, and how does it work?
Livalo (pitavastatin) is a statin drug used to improve blood cholesterol levels in persons with elevated or abnormal blood cholesterol levels.
Livalo is indicated as an adjunctive therapy to diet in:
- Adult patients with primary hyperlipidemia or mixed dyslipidemia to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).
- Pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH) to reduce elevated TC, LDL-C, and Apo B.
Limitations Of Use
- The effect of
Livalo on cardiovascular morbidity and mortality has not been determined.
What are the side effects of Livalo?
Common side effects of Livalo include:
- muscle pain,
- back pain,
- joint pain,
- pain in your arms and legs,
- diarrhea,
- constipation,
- skin rash,
- headache,
- sore throat,
- stuffy or runny nose, and
- flu symptoms.
What is the dosage for Livalo?
General Dosage And Administration Information
- Take Livalo orally once daily with or without food at the same time each day.
- Individualize the dose of
Livalo according to patient characteristics, goal of therapy, and response. - After initiation or upon titration of
Livalo, analyze lipid levels after 4 weeks and adjust the dosage accordingly.
Recommended Dosage For Adults And Pediatric Patients Aged 8 Years And Older
- The recommended starting
Livalo dosage is 2 mg once daily. - The maximum recommended dosage is Livalo 4 mg once daily.
Recommended Dosage In Patients With Renal Impairment
- The recommended starting dose for patients with moderate and severe renal impairment (estimated glomerular filtration rate 30 – 59 mL/minute/1.73 m2 and 15 – 29 mL/minute/1.73 m2, respectively) and patients with end-stage renal disease receiving hemodialysis is
Livalo 1 mg once daily. - The maximum recommended dose for these patients is Livalo 2 mg once daily.
Livalo Dosage Adjustments Due To Drug Interactions
- In patients taking erythromycin, do not exceed Livalo 1 mg once daily.
- In patients taking rifampin, do not exceed Livalo 2 mg once daily.
What drugs interact with Livalo?
Drug Interactions That Increase The Risk Of Myopathy And Rhabdomyolysis With
Livalo
Table 2 includes a list of drugs that increase the risk of myopathy and
rhabdomyolysis when administered concomitantly with Livalo and instructions for
preventing or managing drug interactions.
Table 2: Drug
Interactions that Increase the Risk of Myopathy and Rhabdomyolysis with Livalo
Concomitant use of cyclosporine with Livalo is contraindicated.GemfibrozilClinical Impact:Gemfibrozil may cause myopathy when given alone. The risk of myopathy and rhabdomyolysis is increased with concomitant use of gemfibrozil with statins, including
Livalo.Intervention:Avoid concomitant use of gemfibrozil with
Livalo.ErythromycinClinical Impact:Erythromycin significantly increases pitavastatin exposure and increases the risk of myopathy and rhabdomyolysis.Intervention:In patients taking erythromycin, do not exceed
Livalo 1 mg once daily.RifampinClinical Impact:Rifampin significantly increases peak pitavastatin exposure and increases the risk of myopathy and rhabdomyolysis.Intervention:In patients taking rifampin, do not exceed
Livalo 2 mg once daily.FibratesClinical Impact:Fibrates may cause myopathy when given alone. The risk of myopathy and rhabdomyolysis is increased with concomitant use of fibrates with statins, including
Livalo.Intervention:Consider if the benefit of using fibrates concomitantly with
Livalo outweighs the increased risk of myopathy and rhabdomyolysis.NiacinClinical Impact:The risk of myopathy and rhabdomyolysis may be increased with concomitant use of lipid-modifying doses (≥1 g/day) of niacin with
Livalo.Intervention:Consider if the benefit of using lipid-modifying doses (>1 g/day) of niacin concomitantly with
Livalo outweighs the increased risk of myopathy and rhabdomyolysis.ColchicineClinical Impact:Cases of myopathy and rhabdomyolysis have been reported with concomitant use of colchicine with statins, including
Livalo.Intervention:Consider the risk/benefit of concomitant use of colchicine with
Livalo.
Is Livalo safe to use while pregnant or breastfeeding?
- Livalo is contraindicated for use in pregnant women since safety in pregnant women has not been established and there is no apparent benefit to therapy with
Livalo during pregnancy. - Because HMG-CoA reductase inhibitors decrease cholesterol synthesis and possibly the synthesis of other biologically active substances derived from cholesterol,
Livalo may cause fetal harm when administered to pregnant women. Livalo should be discontinued as soon as pregnancy is recognized. - Livalo is contraindicated during breastfeeding. There is no available information on the effects of the drug on the breastfed infant or the effects of the drug on milk production.
- However, it has been shown that another drug in this class passes into human milk. Because of the potential for serious adverse reactions in a breastfed infant, advise patients that breastfeeding is not recommended during treatment with
Livalo.